TVARDI THERAPEUTICS, INC. (TVRD) Shareholders’ equity 2016–2024
TVARDI THERAPEUTICS, INC. (TVRD) shareholders’ equity at each fiscal year-end, per SEC filings.
-$91.1MFY2024 · since FY2016: $50.7M → -$91.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$91.1M | -46.8% |
| FY2023 | -$62.1M | -139.1% |
| FY2022 | $158.8M | -30.2% |
| FY2021 | $227.5M | -8.6% |
| FY2020 | $249.0M | +33.4% |
| FY2019 | $186.7M | +39.7% |
| FY2018 | $133.6M | +54.0% |
| FY2017 | $86.8M | +71.1% |
| FY2016 | $50.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice